Skip to main content

Table 3 Cervical test positivity rates for various clinical groups

From: Genomic amplification patterns of human telomerase RNA gene and C-MYC in liquid-based cytological specimens used for the detection of high-grade cervical intraepithelial neoplasia

Cytological/histological diagnosis TERC positive cases [% (positive/total)] C-MYC positive cases [% (positive/total)]
NILM-negative 7.3 (8/109) 19.3 (21/109)
NILM-CIN1 0.0 (0/15) 33.3 (5/15)
NILM-CIN2+ 37.5 (3/8) 37.5 (3/8)
ASCUS-negative 12.8 (5/39) 23.1 (9/39)
ASCUS-CIN1 14.3 (1/7) 14.3 (1/7)
ASCUS-CIN2+ 100.0 (4/4) 75.0 (3/4)
LSIL-negative 18.2 (2/11) 36.4 (4/11)
LSIL-CIN1 75.0 (3/4) 50.0 (2/4)
LSIL-CIN2+ 100.0 (6/6) 100.0 (6/6)
ASC-H-negative 0.0 (0/3) 0.0 (0/3)
ASC-H -CIN1 0.0 (0/2) 0.0 (0/2)
ASC-H -CIN2+ 100.0 (9/9) 66.7 (6/9)
HSIL-negative 0.0 (0/2) 0.0 (0/2)
HSIL-CIN1 100.0 (1/1) 100.0 (1/1)
HSIL-CIN2+ 100.0 (20/20) 95.0 (19/20)
SCC-CIN2+ 100.0 (3/3) 100.0 (3/3)